Chronic Hepatitis C Treatment with New Antiviral Agents
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2018, Vol 7, Issue 1
Abstract
Recent advances in our knowledge of hepatitis C virus (HCV) molecular biology have enabled improvements in the efficacy and tolerability of HCV treatment, and in this regard many direct-acting antiviral (DAA) agents have been developed. These drugs target specific stages in the HCV life cycle. Phase 3 clinical trials have demonstrated treatment success rates of 90% with these drugs and their combinations, while real world data indicate a rate of 80-90%. In this review, the use of DAA drugs in the treatment of chronic HCV infection is reviewed in detail.
Authors and Affiliations
Özlem KANDEMİR
Keywords
Related Articles
- EP ID EP689309
- DOI 10.4274/mjima.2018.9
- Views 154
- Downloads 0
Progressive Multifocal Leukoencephalopathy Presenting with Bilateral Myoclonus: A Case Report
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system (CNS) caused by John Cunningham virus lytic infection of the oligodendrocytes, the myelin-producing cells in the C...
Evaluation of Infections in Hospitalised Pregnant Women
Introduction: Hormonal and immunological changes in pregnancy may lead to an increase in infectious diseases caused by some pathogens. In this study, we aimed to determine the types of infections and treatment approaches...
Rational Antibiotic Use: How Much Can Duration of Antibiotic Therapy Be Shortened?
Infectious diseases are conditions with significant consequences in terms of public health while associated mortality, morbidity, and complications can be prevented. Disease severity and duration can be shortened by mean...
Is Urinary Tract Infection Different in Elderly and Adults Aged Under 65 Years? Ege University Experience
Introduction: World population is ageing. Accordingly, the prevalence of health problems and diseases are also increasing. Aging is associated with a growing demand for acute and primary healthcare. Urinary tract infecti...
Mystery of Immune Response in Relapsed Brucellosis: Immunophenotyping and Multiple Cytokine Analysis
Introduction: Brucella spp. are intracellular bacteria that may cause acute, subacute and chronic infections. Despite optimum antibiotic treatment, relapse of brucellosis occurs in some patients. There is less amount of...